2,220 regulatory filings were published by NSE- and BSE-listed companies on 26 June 2026 — showing page 23 of 23.
SAB Industries Ltd · 539112 · BSE ·
The trading window for designated persons and their relatives will be closed in anticipation of the financial results for the quarter ending June 30, 2026. The closure period will begin on July 1, 2026. The trading window will reopen 48 hours after the declaration of the financia…
Chembond Chemicals Limited · CHEMBONDCH · NSE ·
• The trading window for the company's securities will be closed for Designated Persons and their immediate relatives starting from July 1, 2026. • The closure is in anticipation of the declaration of Unaudited Financial Results for the quarter ended June 30, 2026. • The trading…
Shikhar Leasing & Trading Ltd · 507952 · BSE ·
The trading window for the company's shares will be closed for all Designated Persons and their immediate relatives starting from **1st July, 2026**. This closure is in preparation for the declaration of the un-audited financial results for the quarter ending on 30th June, 2026.…
Permanent Magnets Ltd · 504132 · BSE ·
• The trading window will be closed for all Designated Persons from **July 01, 2026**. • This is in preparation for the approval of Unaudited Financial Results for the quarter ending **June 30, 2026**. • The trading window will reopen 48 hours after the financial results are decl…
Ajanta Pharma Limited · AJANTPHARM · NSE ·
The trading window for dealing in the company's securities will be closed for all designated persons and their immediate relatives. The closure period begins on Wednesday, 1st July 2026. The window will reopen 48 hours after the financial results for the quarter ending 30th June…
Chembond Chemicals Limited · CHEMBONDCH · NSE ·
• The company has announced the closure of its trading window ahead of declaring its financial results for the quarter ending June 30, 2026. • The closure period for designated persons is from <b>July 1, 2026, to July 18, 2026</b>. • Financial results are expected to be announced…
GKB Ophthalmics Ltd · 533212 · BSE ·
The trading window for dealing in the company's shares will be closed from **July 01, 2026**. This is in anticipation of the declaration of financial results for the first quarter ending June 30, 2026. The trading restriction applies to all Promoters, Directors, Designated Person…
Lords Mark Industries Ltd · 501261 · BSE ·
The company has announced the closure of its trading window for all designated persons, including Directors, Promoters, and KMPs. The closure period will begin on July 1, 2026. The trading window will reopen 48 hours after the declaration of unaudited financial results for the qu…
Lupin Limited · LUPIN · NSE ·
• Received tentative approval from the U.S. Food and Drug Administration (FDA) for its Enzalutamide Tablets. • The approved strengths are 40 mg, 80 mg, 120 mg, and 160 mg. • This product is a generic equivalent to Astellas Pharma Inc.'s Xtandi® Tablets. • The new 120 mg and 160 m…
Aether Industries Limited · AETHER · NSE ·
• The company has commenced commercial operations at its new "Manufacturing Site 5" effective June 26, 2026. • This expansion is a key part of the company's strategy to increase production capacity and is expected to be a major contributor to future revenue growth. • Operations h…
Gujarat Raffia Industries Limited · GUJRAFFIA · NSE ·
The trading window for dealing in the company's shares will be closed from <b>01st July, 2026</b>. This closure is in view of the upcoming declaration of the <b>Unaudited Standalone Financial Results</b> for the quarter ended 30th June, 2026. The trading window will reopen <b>48…
Edvenswa Enterprises Ltd · 517170 · BSE ·
The company has announced the closure of its trading window for dealing in its securities. This is in anticipation of the upcoming declaration of Un-Audited Financial Results for the quarter ending June 30, 2026. The closure period is from **July 1, 2026, until 48 hours after** t…
Modi Naturals Limited · MODINATUR · NSE ·
• The trading window for insiders will be closed from <b>Wednesday, July 1, 2026</b>. • This closure is in preparation for the announcement of the un-audited financial results for the quarter ending June 30, 2026. • The window will reopen 48 hours after the financial results are…
Unick Fix-A-Form And Printers Ltd · 541503 · BSE ·
The trading window for the company's shares will be closed from **1st July, 2026**. This closure is in anticipation of the announcement of the Unaudited Standalone Financial Results for the quarter ending 30th June, 2026. The trading window will reopen **48 hours after** the fina…
Equippp Social Impact Technologies Limited · EQUIPPP · NSE ·
**Strategic Partnership:** Signed a Memorandum of Understanding (MoU) with the Telangana Academy for Skill and Knowledge (TASK), a department of the Government of Telangana. **'EQUIPPP Fellows Program':** The collaboration will create an exclusive program to develop field-ready p…
Zydus Lifesciences Limited · ZYDUSLIFE · NSE ·
Zydus has entered into a 50:50 joint venture (JV) with Sunshine Healthcare Lanka Limited in Sri Lanka. The JV, named Zydus Sunshine Lifesciences, will establish a pharmaceutical manufacturing facility to produce medicines for the local market. Zydus will invest up to USD 5 millio…
JK Cement Limited · JKCEMENT · NSE ·
• <b>32nd Annual General Meeting (AGM):</b> Scheduled to be held on Friday, July 17, 2026, at 11:00 AM via video conference. • <b>Proposed Final Dividend:</b> The Board has recommended a final dividend of ₹20 per equity share for the financial year 2025-26, subject to shareholder…
Power & Instrumentation (Gujarat) Limited · PIGL · NSE ·
The trading window for the company's securities will be closed starting **Wednesday, July 1, 2026**. The closure is in preparation for the declaration of the Un-Audited Financial Results for the quarter ending June 30, 2026. The window will reopen 48 hours after the financial res…
Jubilant Pharmova Limited · JUBLPHARMA · NSE ·
Jubilant Generics Limited, a subsidiary, has received <b>tentative approval</b> from the USFDA. The approval is for <b>Pantoprazole Sodium Delayed Release Oral Suspension</b>, 40 mg. Final approval is contingent on the patent expiry of the reference drug, which is expected in <b>…
JK Cement Limited · JKCEMENT · NSE ·
• <b>Strong Financial Performance:</b> Consolidated Revenue grew 15.5% YoY to ₹13,722 Crores, while Profit After Tax (PAT) rose 13.3% to ₹988 Crores for FY 2025-26. • <b>Record Grey Cement Volume:</b> The Grey Cement segment achieved a historic milestone, with volumes growing 15%…
